Article Versions Notes

Elfaki I, Mir R, Duhier FMA, Alotaibi MA, Alalawy AI, Barnawi J, Babakr AT, Mir MM, Altayeb F, Mirghani H, et al. Clinical Implications of MiR128, Angiotensin I Converting Enzyme and Vascular Endothelial Growth Factor Gene Abnormalities and Their Association with T2D. Current Issues in Molecular Biology. 2021; 43(3):1859-1875. https://doi.org/10.3390/cimb43030130

Elfaki, Imadeldin, Rashid Mir, Faisel M. Abu Duhier, Maeidh A. Alotaibi, Adel Ibrahim Alalawy, Jameel Barnawi, Abdullatif Taha Babakr, Mohammad Muzaffar Mir, Faris Altayeb, Hyder Mirghani, and et al. 2021. "Clinical Implications of MiR128, Angiotensin I Converting Enzyme and Vascular Endothelial Growth Factor Gene Abnormalities and Their Association with T2D" Current Issues in Molecular Biology 43, no. 3: 1859-1875. https://doi.org/10.3390/cimb43030130

Elfaki, I., Mir, R., Duhier, F. M. A., Alotaibi, M. A., Alalawy, A. I., Barnawi, J., Babakr, A. T., Mir, M. M., Altayeb, F., Mirghani, H., & Frah, E. A. M. (2021). Clinical Implications of MiR128, Angiotensin I Converting Enzyme and Vascular Endothelial Growth Factor Gene Abnormalities and Their Association with T2D. Current Issues in Molecular Biology, 43(3), 1859-1875. https://doi.org/10.3390/cimb43030130